Quick Answer
AVITA Medical, Inc. reported Cash and Equivalents of $10.24 million for fiscal year 2025.
AVITA Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $10.24M | -27.1% |
| 2024 | $14.05M | -36.5% |
| 2023 | $22.12M | +21.8% |
| 2022 | $18.16M | -67.3% |
| 2021 | $55.51M | -49.9% |
| 2021 | $110.75M | +50.4% |
| 2020 | $73.64M | +265.0% |
| 2019 | $20.17M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.42M | -17.3% | +26.2% |
| June 30, 2025 | $12.22M | -30.0% | -17.8% |
| March 31, 2025 | $14.87M | -12.3% | +5.8% |
| December 31, 2024 | $14.05M | -36.5% | -24.6% |
| September 30, 2024 | $18.64M | -63.3% | +6.8% |
| June 30, 2024 | $17.45M | -53.4% | +3.0% |
| March 31, 2024 | $16.95M | -39.6% | -23.4% |
| December 31, 2023 | $22.12M | +21.8% | -56.5% |
- AVITA Medical, Inc. showed a decrease of -27.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, AVITA Medical, Inc.’s cash and equivalents has declined by 49.2% (from $20.17 million to $10.24 million).
- The most recent figure is from AVITA Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: